MedTrace Logo

Sorrel 25R Injector - Sorrel Clinical Study Protocol

NCT05221333 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-02-03

No results posted yet for this study

Summary

A prospective, open-label, single-center pilot study to evaluate the performance, safety and usability of the investigational SWI Device in healthy volunteers.

Conditions

  • Injection Site
  • Injection Site Reaction
  • Injection Site Irritation

Interventions

DEVICE

Sorrel Wearable Injector

Use of Sorrel Wearable Injector in pilot study

Sponsors & Collaborators

  • Thomas Jefferson University

    collaborator OTHER

  • Eitan Medical

    lead INDUSTRY

Principal Investigators

  • Marc C Torjman · Thomas Jefferson University

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-23
Primary Completion
2022-12-15
Completion
2022-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05221333 on ClinicalTrials.gov